Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia

NCT00006084 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: lintuzumab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]